Karuna Therapeutics' top-experimental schizophrenia drug significantly reduced symptoms in a late-stage trial but there were concerns that it could cause hypertension in patients.

Share:
More In Science
Paying to Sponsor an Ocean
A small island in the Pacific is offering people the chance to help protect its waters by becoming a sponsor of the ocean.
Load More